Celularity Inc. CELU
Set alert
0.80 USD 0.00 +0.30%
At close · Nov 2
0.79 -0.01 -1.56%
After hours · Nov 2, 4:00 PM ET
0.79 Day range 0.86
0.56 52-week range 2.55
- YTD
- -27.70%
- 1 year
- -58.85%
- Open
- 0.80
- Prev close
- 0.8001
- Mkt cap
- 26.04M
- Vol
- 98.69K
- Avg vol
- 3.92M
- EPS
- -1.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.79
- High
- 0.86
- Forward P/E
- -4.00
- Beta
- 0.51
- Short ratio
- 0.36
- Inst. own
- 14.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 16, 2024
- 50-d avg
- 2.38
- 200-d avg
- 3.15
- 1y target
- 0.00
3M chart
Signals (14)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| RSI: Overbought | Aug 31, 2026 | 2 months ago |
| RSI: Overbought | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
Financial health
Altman Z-Score
-16.24 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.3×
FY 2018 5y median -0.3× FY 2025
P/S 1.1×
FY 2018 5y median 1.9× FY 2025
P/B -0.7×
FY 2018 5y median 1.1× FY 2025
P/FCF -2.1×
FY 2018 5y median -2.1× FY 2025
EV/EBITDA -0.8×
FY 2018 5y median -1.7× FY 2025
EV/Sales 2.4×
FY 2018 5y median 4.8× FY 2025
FCF Yield -46.6%
FY 2018 5y median -46.6% FY 2025
Profitability
Gross Margin 24.4%
FY 2018 5y median 29.7% FY 2025
Operating Margin -230.9%
FY 2018 5y median -230.9% FY 2025
Net Margin -345.4%
FY 2018 5y median -345.4% FY 2025
ROE 241.0%
FY 2018 5y median -100.7% FY 2025
ROIC -151.1%
FY 2018 5y median -44.9% FY 2025
ROA -85.5%
FY 2018 5y median -43.6% FY 2025
Growth (YoY)
Revenue -51.0%
FY 2018 FY 2025
Operating Income -59.8%
FY 2018 FY 2025
EPS (diluted) -35.7%
FY 2018 FY 2025
Free Cash Flow -102.0%
FY 2018 FY 2025
Financial Health
Current Ratio 0.2×
FY 2018 5y median 0.4× FY 2025
Quick Ratio 0.1×
FY 2018 5y median 0.3× FY 2025
Debt / Equity -1.1×
FY 2018 5y median 0.3× FY 2025
Net Debt / EBITDA -0.4×
FY 2018 5y median -0.4× FY 2025
Interest Coverage -9.1×
FY 2018 5y median -9.1× FY 2025
Dividends
Dividend Yield 20.8%
FY 2018 5y median 0.0% FY 2025
Payout Ratio -6.4%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
